title: Tocilizumab for polymyalgia rheumatica: a first or second line?
authors.affiliation: Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.
authors.forename: Sergey
authors.initials: S
authors.lastname: Moiseev
authors.affiliation: Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.
authors.forename: Pavel
authors.initials: P
authors.lastname: Novikov
authors.affiliation: Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.
authors.forename: Victor
authors.initials: V
authors.lastname: Fomin
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D013700:Giant Cell Arteritis; D006801:Humans; D011111:Polymyalgia Rheumatica
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C502936:tocilizumab
keywords: Polymyalgia Rheumatica; Systemic vasculitis; Treatment